Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
July 5, 2019
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome
Marc G Berger, Bruno Pereira, Philippe Rousselot, et al.
Scientific Reports
|
March 18, 2021
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34<sup>-</sup> and immature CD34<sup>+</sup> cells
Marc G Berger, Benjamin Lebecque, Thomas Tassin, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 30, 2012
Measurement of imatinib uptake by flow cytometry
Céline Bourgne, Mahchid Bamdad, Alexandre Janel, et al.
Clinical Pharmacokinetics
|
August 22, 2018
Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1
Juliette Berger, Marie Vigan, Bruno Pereira, et al.
Journal of Inherited Metabolic Disease
|
March 20, 2025
Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-Up
Alberto Nasce, Yann Nguyen, Nadia Belmatoug, et al.
Leukemia
|
August 1, 2025
Evaluating a predictive model of tyrosine kinase inhibitor therapy failure in a European-type cohort: a step towards population-specific tools
Sylvain Moinard, Benjamin Lebecque, Tom Lachaise, et al.
Orphanet Journal of Rare Diseases
|
October 28, 2025
French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease
Fabrice Camou, Christine Serratrice, Magali Pettazzoni, et al.
Orphanet Journal of Rare Diseases
|
October 11, 2012
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients
Jérôme Stirnemann, Marie Vigan, Dalil Hamroun, et al.
Leukemia
|
July 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
Fabio Efficace, Francois-Xavier Mahon, Johan Richter, et al.
Orphanet Journal of Rare Diseases
|
February 14, 2026
Impact of COVID-19 infection in patients with inherited metabolic diseases: a National Multicenter Study from the French IMDs Healthcare Network for Rare Diseases
Claire Douillard, Aurélia Poujois, Nadia Belmatoug, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
July 5, 2019
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome
Marc G Berger, Bruno Pereira, Philippe Rousselot, et al.
Scientific Reports
|
March 18, 2021
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34<sup>-</sup> and immature CD34<sup>+</sup> cells
Marc G Berger, Benjamin Lebecque, Thomas Tassin, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 30, 2012
Measurement of imatinib uptake by flow cytometry
Céline Bourgne, Mahchid Bamdad, Alexandre Janel, et al.
Clinical Pharmacokinetics
|
August 22, 2018
Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1
Juliette Berger, Marie Vigan, Bruno Pereira, et al.
Journal of Inherited Metabolic Disease
|
March 20, 2025
Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-Up
Alberto Nasce, Yann Nguyen, Nadia Belmatoug, et al.
Leukemia
|
August 1, 2025
Evaluating a predictive model of tyrosine kinase inhibitor therapy failure in a European-type cohort: a step towards population-specific tools
Sylvain Moinard, Benjamin Lebecque, Tom Lachaise, et al.
Orphanet Journal of Rare Diseases
|
October 28, 2025
French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease
Fabrice Camou, Christine Serratrice, Magali Pettazzoni, et al.
Orphanet Journal of Rare Diseases
|
October 11, 2012
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients
Jérôme Stirnemann, Marie Vigan, Dalil Hamroun, et al.
Leukemia
|
July 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
Fabio Efficace, Francois-Xavier Mahon, Johan Richter, et al.
Orphanet Journal of Rare Diseases
|
February 14, 2026
Impact of COVID-19 infection in patients with inherited metabolic diseases: a National Multicenter Study from the French IMDs Healthcare Network for Rare Diseases
Claire Douillard, Aurélia Poujois, Nadia Belmatoug, et al.
Page
of 6